Skip to content

News & Insights

Conformis Continues Litigations Against Patient-Specific Medical Technologies
On June 3, 2021, Conformis continued its patent enforcement efforts involving patient-specific technologies by filing suit against Bodyhub and Exactech in the Middle District of Florida. In a first complaint,...
UCLA Biodesign Launches Study to Help Advance MedTech and Digital Health Innovation Forward Into a New Decade
What does it require to bring a transformational innovation to patients?  To address this question, the UCLA Biodesign Hub for MedTech and Digital Health has launched an industry-wide study to...
Philips Acquires BioTelemetry for $2.8B
Royal Philips NV acquired BioTelemetry, Inc. for $2.8 billion US dollars. Headquartered in Malvern, Pennsylvania, BioTelemetry provides cardiac diagnostics and monitoring tools that, according to the press release, are expected...
UCLA BIODESIGN IS SEEKING INNOVATIVE PROFESSIONALS FOR ITS 2021 FELLOWSHIP PROGRAM
  UCLA Biodesign is currently inviting professionals in engineering, medicine, design, computer science, and business to apply for an exciting year-long fellowship, starting in the summer of 2021, associated with...
Medtronic Gains FDA and CE Mark Clearance for LINQ II
Medtronic recently announced that it received clearance from the FDA and CE Mark approval for its LINQ II insertable cardiac monitor (ICM). The announcement notes that ICMs “are small, subcutaneously...
One-Stop-Shop Apps for COVID-19 Information
COVID-19-related web applications have been popping up from the very start of the pandemic, and many, including Apple and others, have stepped up to contribute to the developments. The majority...
Balancing Intellectual Property (IP) Interests with National Interest in Response to the Coronavirus
Traditionally, it has been fairly uncommon to see new legislation in intellectual property (IP) law, compared to other areas of law.  Instead, courts have generally been the avenue through which...
close modal